stockrow
Friday 6 November 2026
Export LFST’s income statement to Excel — free account
LifeStance Health Group, Inc.
LFST Healthcare Medical Care Facilities
LifeStance Health Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.4 billion, up 13.9% from fiscal 2024.
- Revenue
- +25.3%
- EPS
- +2,042.9%
- Free cash flow
- +31.6%
- Total debt
- −5.15%
Quarter to September 2026, against a year earlier
13.85
0.42
+3.13%
Follow LFST
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 From the 10-Q filed 5 Nov | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
283.87 | 101.11 | 80.53 | 63.25 |
P/S ratio |
1.91 | 1.65 | 2.59 | 2.73 | |
P/FCF ratio |
24.70 | 17.30 | 23.62 | 25.58 | |
P/Operating CF |
47.21 | 74.51 | 41.11 | 123.89 | |
P/B ratio |
1.79 | 1.67 | 2.78 | 3.07 | |
Price to Tangible BV |
54.35 | 467.56 | 0.00 | 270.39 | |
EV/Sales |
1.92 | 1.70 | 2.61 | 2.76 | |
EV/EBITDA |
34.22 | 25.30 | 30.90 | 28.70 | |
EV/Operating CF |
18.71 | 13.90 | 19.00 | 20.31 | |
EV/FCF |
24.86 | 17.77 | 23.81 | 25.79 | |
Quick Ratio |
1.37 | 1.33 | 1.23 | 1.30 | |
Current Ratio |
1.65 | 1.48 | 1.38 | 1.44 | |
Net Debt/EBITDA |
0.54 | 1.89 | 0.73 | 0.76 | |
Debt/Assets |
12.07% | 12.23% | 11.87% | 11.69% | |
Debt/Equity |
0.17 | 0.18 | 0.18 | 0.17 | |
Asset Turnover |
0.66 | 0.70 | 0.73 | 0.77 | |
Operating CF/Net income |
4.93 | 2.32 | 4.23 | 1.65 | |
Capex/Depreciation |
(0.80) | (0.79) | (0.83) | (0.96) | |
Interest Coverage |
6.29 | 12.43 | 11.65 | 13.28 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
24.80% | 24.87% | 24.84% | 24.87% | |
Intangible Assets out of Total Assets |
0.67 | 0.69 | 0.68 | 0.67 | |
Share Based Compensation of Revenue |
4.37% | 3.77% | 4.54% | 3.99% | |
Graham Net Nets |
(0.10) | (0.13) | (0.08) | (0.07) | |
Graham Number |
1.48 | 2.33 | 3.40 | 4.09 | |
Earnings Yield |
0.35% | 0.99% | 1.24% | 1.58% | |
Free Cash Flow Yield |
4.05% | 5.78% | 4.23% | 3.91% | |
Revenue per Share |
0.99 | 1.04 | 1.14 | 1.20 | |
Operating CF per Share |
0.15 | 0.09 | 0.26 | 0.10 | |
Capex per Share |
(0.03) | (0.03) | (0.03) | (0.04) | |
Free Cash Flow per Share |
0.12 | 0.06 | 0.23 | 0.06 | |
Cash per Share |
0.64 | 0.50 | 0.59 | 0.57 | |
Shareholders Equity per Share |
3.94 | 3.82 | 3.85 | 3.91 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
3.94 | 3.82 | 3.85 | 3.91 | |
Free Cash Flow |
46.65 | 22.34 | 87.92 | 22.36 | |
Working Capital |
164.24 | 116.18 | 103.21 | 115.65 | |
Capital Expenditures |
(10.91) | (10.77) | (11.99) | (14.65) | |
Net Current Asset Value |
(266.72) | (312.55) | (326.38) | (317.11) | |
EV/EBIT |
113.25 | 56.54 | 52.79 | 44.41 | |
Capex to Sales |
0.03 | 0.03 | 0.03 | 0.03 | |
Price to Operating Income |
112.54 | 55.03 | 52.37 | 44.05 | |
| Other line items | |||||
Average Receivables |
113.76 | 131.64 | 120.22 | 121.01 | |
Average Payables |
6.68 | 5.85 | 9.42 | 8.86 | |
Average Assets |
2,161.12 | 2,125.28 | 2,164.15 | 2,167.63 | |
Average Common Equity |
1,483.65 | 1,467.26 | 1,475.53 | 1,492.57 |
Columns are period end dates · fundamentals updated 5 Nov 2026